We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Lamar Advertising Co
LAMR
$16.5B
| $11.8M | 0.03% |
142,966
+20,930
| +17% | +$1.99M |
|
352
Principal Financial Group
PFG
$24.6B
| $11.8M | 0.03% |
163,015
+74,660
| +85% | +$5.36M |
|
353
Cintas
CTAS
$86B
| $11.7M | 0.03% |
120,272
-720
| -0.6% | -$73.5K |
|
354
Ginkgo Bioworks
DNA
$503M
| $11.7M | 0.03% |
93,513
| – | – |
|
|
GBT
355
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11.5M | 0.03% |
168,180
+75,416
| +81% | +$4.16M |
|
356
Arthur J. Gallagher & Co
AJG
$68.2B
| $11.3M | 0.03% |
66,153
-1,255
| -2% | -$223K |
|
357
NetApp
NTAP
$34.2B
| $11.3M | 0.03% |
182,902
+61,955
| +51% | +$4.31M |
|
358
Idexx Laboratories
IDXX
$44.9B
| $11.3M | 0.03% |
34,534
-4,257
| -11% | -$1.56M |
|
|
ISEE
359
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $11.2M | 0.03% |
626,624
+185,886
| +42% | +$2.44M |
|
360
CenterPoint Energy
CNP
$28.8B
| $11.2M | 0.03% |
396,495
+19,740
| +5% | +$616K |
|
361
Louisiana-Pacific
LPX
$5.35B
| $11.1M | 0.03% |
217,420
+4,270
| +2% | +$243K |
|
362
Generac Holdings
GNRC
$11.5B
| $11M | 0.03% |
61,835
-300
| -0.5% | -$68.8K |
|
363
Evercore
EVR
$13.2B
| $11M | 0.03% |
133,339
+23,910
| +22% | +$2.26M |
|
364
Amphenol
APH
$177B
| $10.9M | 0.03% |
326,612
-2,070
| -0.6% | -$75.2K |
|
365
Lumen
LUMN
$6.38B
| $10.9M | 0.03% |
1,500,587
+559,615
| +59% | +$5.69M |
|
366
Snap-on
SNA
$21.7B
| $10.9M | 0.03% |
54,096
-2,990
| -5% | -$645K |
|
|
ANSS
367
DELISTED
Ansys
ANSS
| $10.8M | 0.03% |
48,524
-592
| -1% | -$151K |
|
368
Raymond James Financial
RJF
$34B
| $10.8M | 0.03% |
108,850
+12,735
| +13% | +$1.29M |
|
369
Cencora
COR
$62.2B
| $10.7M | 0.03% |
79,077
-35,520
| -31% | -$5.1M |
|
370
CMS Energy
CMS
$23B
| $10.7M | 0.03% |
183,320
-77,010
| -30% | -$5.18M |
|
371
Darden Restaurants
DRI
$23.7B
| $10.7M | 0.03% |
84,336
-31,796
| -27% | -$3.97M |
|
372
Freeport-McMoran
FCX
$88.6B
| $10.5M | 0.03% |
385,574
-627,900
| -62% | -$18.4M |
|
373
M&T Bank
MTB
$36.6B
| $10.5M | 0.03% |
59,361
+16,810
| +40% | +$2.97M |
|
374
Gen Digital
GEN
$16.6B
| $10.4M | 0.03% |
516,733
-47,535
| -8% | -$1.1M |
|
375
Zscaler
ZS
$24.5B
| $10.3M | 0.03% |
62,360
+28,810
| +86% | +$4.71M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.